Mesa Laboratories
(NASDAQ) MLAB
Mesa Laboratories Financials at a Glance
Market Cap
$602.38M
Revenue (TTM)
$249.13M
Net Income (TTM)
$6.71M
EPS (TTM)
$1.21
P/E Ratio
90.29
Dividend
$0.64
Beta (Volatility)
1.17 (Average)
Dividend
$0.64
Beta (Volatility)
1.17 (Average)
Price
$107.18
Volume
4,258
Open
$109.36
Price
$107.18
Volume
4,258
Open
$109.36
Previous Close
$107.18
Daily Range
$106.55 - $109.65
52-Week Range
$55.45 - $113.99
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.64
Beta (Volatility)
1.17 (Average)
Price
$107.18
Volume
4,258
Open
$109.36
Previous Close
$107.18
Daily Range
$106.55 - $109.65
52-Week Range
$55.45 - $113.99
Estimated Earnings Date
Aug 5, 2026
MLAB News
MLAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mesa Laboratories
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
717
CEO
Gary M. Owens, MBA
Website
www.mesalabs.comHeadquarters
Lakewood, CO 80228, US
MLAB Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
7%
Net Income Margin
3%
Return on Equity
4%
Return on Capital
5%
Return on Assets
2%
Earnings Yield
1.11%
Dividend Yield
0.59%
Payout Ratio
52.49%
Stock Overview
Market Cap
$602.38M
Shares Outstanding
5.52M
Volume
4.26K
Avg. Volume
147.39K
Financials (TTM)
Gross Profit
$158.27M
Operating Income
$18.51M
EBITDA
$41.78M
Operating Cash Flow
$42.83M
Capital Expenditure
-$3.25M
Free Cash Flow
$39.58M
Cash & ST Invst.
$26.93M
Total Debt
$90.13M
Mesa Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$63.72M
+2.6%
Gross Profit
$46.65M
+21.4%
Gross Margin
73.21%
N/A
Market Cap
$602.38M
N/A
Market Cap/Employee
$818.46K
N/A
Employees
736
N/A
Net Income
-$4.14M
+41.9%
EBITDA
$8.50M
-18.9%
Quarterly Fundamentals
Total Cash
$26.93M
-1.4%
Total Debt
$90.13M
-50.3%
Accounts Receivable
$44.10M
+5.1%
Inventory
$0.00
-100.0%
Long Term Debt
$84.50M
+9.9%
Short Term Debt
$5.63M
-94.6%
Return on Assets
1.57%
N/A
Return on Invested Capital
5.06%
N/A
Free Cash Flow
$16.80M
+44.1%
Operating Cash Flow
$13.96M
+10.2%